Diabetes Care Publish Ahead of Print published online ahead of print January 9, 2008 DOI: 10.2337/dc07-1657
Retinal vascular lesions in patients with type 2 diabetes mellitus of Caucasian and Asian origin - baseline results from the AdRem study
Ronald P. Stolk, MD1,,2,
Mary J. van Schooneveld, MD2,
J. Kennedy Cruickshank, MD3,
Alun D. Hughes, PhD4,
Alice Stanton, MD5,
Juming Lu, MD6,
Anushka Patel, MD7,
Simon A. McG. Thom, MD4,
Diederick E. Grobbee, MD2,
Johannes R. Vingerling, MD on behalf of the AdRem project team, ADVANCE management committee8,,9
1 Department of Epidemiology, University Medical Center Groningen, University of Groningen, The Netherlands
2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
3 Cardiovascular Sciences Research Group, University of Manchester & Royal Infirmary, Manchester, United Kingdom
4 International Centre for Circulatory Health, National Heart & Lung Institute, Imperial College London, United Kingdom
5 Molecular and Cellular Therapeutics and RCSI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland
6 Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
7 The George Institute for International Health, University of Sydney, Sydney, Australia
8 Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands
9 Department of Epidemiology & Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands
R.P.Stolk{at}epi.umcg.nl
ABSTRACT
Objective: To describe prevalent vascular retinal lesions among patients with type 2 diabetes enrolled in the ADVANCE Retinal measurement study (AdRem), a sub-study of the Action in Diabetes and Vascular disease – Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
Research Design and Methods: Seven field stereoscopic photographs of both eyes were obtained at the baseline assessment of ADVANCE. All photographs were graded in a central reading center. Gradable retinal images were received from 1605 patients.
Results: The number of patients with any retinopathy (ETDRS score 20) was 645 (40.2%, 95%CI 37.8-42.6), of these 35 (2.2%, 1.6-3.0) had severe diabetic retinopathy (ETDRS 50). Focal arterial narrowing, venous beading and arteriovenous (AV) nicking were present in 3.8%, 5.1% and 9.8% of participants, respectively. Among participants included in this study, Chinese and South-Asian patients had more retinopathy than Caucasians, as defined both by ETDRS (49.4%, 46.0%, 31.3%; p<0.001 adjusted for age, gender, HbA1c, systolic blood pressure and duration of diabetes) and specific vascular lesions (e.g. AV nicking 12.3%, 8.5%, 7.5%; adjusted p<0.005). HbA1c, duration of diabetes and systolic blood pressure were similarly associated with increased retinal lesions in Chinese, South-Asian and Caucasian patients.
Conclusions: Using a sensitive diagnostic procedure, more than one third of patients with type 2 diabetes enrolled in AdRem had retinal lesions at baseline. Despite differences in prevalence and severity of retinopathy between Chinese, South-Asian and Caucasian patients included in this study, the cross-sectional associations between established risk factors for retinopathy and retinal lesions were similar across ethnic groups.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2008 by the American Diabetes Association.
|
|
| |
|